Welcure Drugs & Pharmaceuticals Ltd. Reports Unaudited Standalone Earnings Results for Third Quarter and Nine Months Ended December 31, 2014
For the nine months, the company's total income was INR 0.393 million compared to INR 0.121 million a year ago. Net loss for the period was INR 0.017 million compared to INR 0.254 million a year ago.